STUDY PROGRAMME PHARMACOLOGY IN THE STUDY FIELD PHARMACY (Department of pharmacology a toxikology)
STUDY PROGRAMME PHARMACOLOGY IN THE STUDY FIELD PHARMACY (Department of pharmacology a toxikology)
Job Information Organisation/Company Centre of Experimental Medicine SAS Department Department of pharmacology of inflammation Research Field Pharmacological sciences » Pharmacy Researcher Profile First Stage Researcher (R1) Country Slovakia Application Deadline … Read More Read More
Categories:
PULSE-CF: Polymicrobial communities in the Cystic Fibrosis (CF) airways-role in infection and pulmonary exacerbations.
PULSE-CF: Polymicrobial communities in the Cystic Fibrosis (CF) airways-role in infection and pulmonary exacerbations.
About the Project The PULSE-CF Innovation Hub is one of four translational hubs being supported by the CF Trust and LifeArc over the next 5 years. The Hub is a … Read More Read More
Categories:
PULSE-CF: Enhanced microbiological surveillance in people with Cystic Fibrosis (pwCF)
PULSE-CF: Enhanced microbiological surveillance in people with Cystic Fibrosis (pwCF)
About the Project The PULSE-CF Innovation Hub is one of four translational hubs being supported by the CF Trust and LifeArc over the next 5 years. The Hub is a … Read More Read More
Categories:
Molecular Silencing of Epithelial Sodium Channel (ENaC) using a Peptide Technology to Deliver Treatment for Cystic Fibrosis
Molecular Silencing of Epithelial Sodium Channel (ENaC) using a Peptide Technology to Deliver Treatment for Cystic Fibrosis
About the Project Cystic fibrosis (CF) is an autosomal recessive disease characterized by a progressive decline in lung function and tissue damage associated with mucus obstruction of the airways, impaired … Read More Read More
Category:
3D-printing of implantable devices for sustained drug delivery
3D-printing of implantable devices for sustained drug delivery
About the Project The demand for customised medical devices is driving growth in the 3D-printing medical device market, valued at US$3.76 billion and growing at 14% annually. Developing patient-specific devices … Read More Read More
Categories:
The Development of a Robust Risk-Based Approach to the use of Hot Melt Extrusion for the Manufacture of Amorphous Solid Dispersions
The Development of a Robust Risk-Based Approach to the use of Hot Melt Extrusion for the Manufacture of Amorphous Solid Dispersions
About the Project This project builds upon the extensive experience within the Pharmaceutical Engineering team at the School of Pharmacy to develop a risk-based approach to evaluate the suitability of … Read More Read More
Categories:
Elucidating novel anti-cancer drug responses in advanced ovarian cancer
Elucidating novel anti-cancer drug responses in advanced ovarian cancer
About the Project Ovarian cancer is one of the most lethal gynaecological malignancies, often diagnosed at advanced stages due to non-specific symptoms and a lack of early detection methods. The … Read More Read More
Category:
Developing and characterising novel targeted nanocomposites serving as adjuvants to existing standard-of-care cancer treatments
Developing and characterising novel targeted nanocomposites serving as adjuvants to existing standard-of-care cancer treatments
About the Project One in two cancer patients will receive radiotherapy as part of their standard-of-care treatment. For patients with a localised cancer diagnosis effective radiotherapy represents the best chance … Read More Read More
Category:
Development of a Dual Nanogel for Junctional Epidermolysis Bullosa
Development of a Dual Nanogel for Junctional Epidermolysis Bullosa
About the Project Junctional Epidermolysis Bullosa (JEB) is a debilitating disease where a weak interface between the dermis and epidermis leaves the skin prone to delamination and blistering. JEB accounts … Read More Read More
Category:
Design and Evaluation of an eye-on-a-chip Microfluidic Device
Design and Evaluation of an eye-on-a-chip Microfluidic Device
About the Project With the increasing prevalence of debilitating eye diseases such as age-related macular degeneration, glaucoma, and dry-eye syndromes, there is a pressing need for the development of novel … Read More Read More
Category: